GoodRx Holdings, Inc. (GDRX) Stock Analysis

Company Overview

GoodRx Holdings, Inc. (GDRX) is capitalised at $1.19B on the latest close. It is classified in the Health Information Services industry, within the Healthcare sector. Headcount on file is 697.

The most recent close on file for GDRX is $3.48, dated September 4, 2026. That is −$0.05 (−1.42%) against the previous close. Over the past 52 weeks the price has ranged from $1.77 to $5.81. The latest close sits 96.61% above that 52-week low.

Financial Health

In fiscal 2025, GoodRx Holdings, Inc. reported revenue of $796.85M. That is +0.57% against the prior fiscal year, when revenue was $792.32M. The same year closed with net income of $30.44M. That is +85.72% against the prior fiscal year. Profit margin runs at 2.07%. That is 2.1 percentage points above the Health Information Services median of 0%. Trailing earnings per share are 0.06.

Across the 4 fiscal years on file, revenue moves from $766.55M in 2022 to $796.85M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 58. That is 41.02% above the Health Information Services median of 41.13. On forward earnings the ratio is 9.76. The price-to-sales ratio is 1.51. On price-to-sales that is 43.14% below the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −18.69%. Measured over 5 years, that is −39.15% a year compounded. The reported beta is 1.6. Annualized volatility over the trailing 6 years is 71.69%.

Growth & Income

The record shows no dividend for GDRX.

Across the complete calendar years on file, 2023 returned +43.78% and 2022 returned −85.74%. Of the 5 complete calendar years on file, 1 finished higher. 2026 is still running; the price is +28.41% year to date.